Rania M. El-Lababidi

900 total citations · 1 hit paper
26 papers, 563 citations indexed

About

Rania M. El-Lababidi is a scholar working on Infectious Diseases, Applied Microbiology and Biotechnology and Epidemiology. According to data from OpenAlex, Rania M. El-Lababidi has authored 26 papers receiving a total of 563 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 9 papers in Applied Microbiology and Biotechnology and 7 papers in Epidemiology. Recurrent topics in Rania M. El-Lababidi's work include Antibiotic Use and Resistance (9 papers), Antibiotic Resistance in Bacteria (6 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Rania M. El-Lababidi is often cited by papers focused on Antibiotic Use and Resistance (9 papers), Antibiotic Resistance in Bacteria (6 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Rania M. El-Lababidi collaborates with scholars based in United States, United Arab Emirates and Lebanon. Rania M. El-Lababidi's co-authors include John G. Rizk, Saad I. Mallah, Manaf AlQahtani, Tharmegan Tharmaratnam, Pardeep Sidhu, Omar Ghorab, Mina Iskandar, Bassam Atallah, Elias B. Chahine and Ahmad Nusair and has published in prestigious journals such as Frontiers in Pharmacology, International Journal of Infectious Diseases and Journal of Clinical Medicine.

In The Last Decade

Rania M. El-Lababidi

25 papers receiving 544 citations

Hit Papers

COVID-19: breaking down a global health crisis 2021 2026 2022 2024 2021 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. COVID-19: breaking down a global health crisis
    2021 206 citations Saad I. Mallah, Omar Ghorab et al. Annals of Clinical Microbiology and Antimicrobials profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rania M. El-Lababidi United States 10 172 142 109 97 95 26 563
Simone Mornese Pinna Italy 12 223 1.3× 95 0.7× 84 0.8× 142 1.5× 61 0.6× 46 589
Yin Mo Singapore 14 206 1.2× 101 0.7× 52 0.5× 115 1.2× 78 0.8× 40 546
Mariano Bernardo Italy 13 168 1.0× 282 2.0× 97 0.9× 132 1.4× 37 0.4× 30 661
Tommaso Lupia Italy 16 348 2.0× 169 1.2× 169 1.6× 237 2.4× 99 1.0× 80 954
Navaneeth Narayanan United States 14 286 1.7× 74 0.5× 62 0.6× 219 2.3× 108 1.1× 47 659
Hamad Abdel Hadi Qatar 11 163 0.9× 201 1.4× 53 0.5× 97 1.0× 200 2.1× 47 487
Francesco Vladimiro Segala Italy 11 186 1.1× 62 0.4× 41 0.4× 108 1.1× 80 0.8× 42 489
Mónica Gordón Spain 16 164 1.0× 76 0.5× 99 0.9× 184 1.9× 84 0.9× 44 580
Erin K McCreary United States 11 248 1.4× 133 0.9× 130 1.2× 162 1.7× 97 1.0× 49 533
Ícaro Boszczowski Brazil 14 84 0.5× 199 1.4× 72 0.7× 112 1.2× 160 1.7× 40 550

Countries citing papers authored by Rania M. El-Lababidi

Since Specialization
Citations

This map shows the geographic impact of Rania M. El-Lababidi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rania M. El-Lababidi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rania M. El-Lababidi more than expected).

Fields of papers citing papers by Rania M. El-Lababidi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rania M. El-Lababidi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rania M. El-Lababidi. The network helps show where Rania M. El-Lababidi may publish in the future.

Co-authorship network of co-authors of Rania M. El-Lababidi

This figure shows the co-authorship network connecting the top 25 collaborators of Rania M. El-Lababidi. A scholar is included among the top collaborators of Rania M. El-Lababidi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rania M. El-Lababidi. Rania M. El-Lababidi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
El-Lababidi, Rania M., et al.. (2025). Clinical Outcomes Amongst Patients Infected With Candida Auris: A Single‐Center Study. Mycoses. 68(4). e70054–e70054. 1 indexed citations
2.
Nekidy, Wasim S. El, et al.. (2024). The Impact of Clinical Pharmacist-Driven Weekend Antimicrobial Stewardship Coverage at a Quaternary Hospital. Antibiotics. 13(10). 974–974. 4 indexed citations
3.
4.
Nekidy, Wasim S. El, Islam M. Ghazi, Rania M. El-Lababidi, et al.. (2024). Clinical Outcomes of Trimethoprim/Sulfamethoxazole in Critically Ill Patients with Stenotrophomonas maltophilia Bacteremia and Pneumonia Utilizing Renal Replacement Therapies. Journal of Clinical Medicine. 13(8). 2275–2275. 1 indexed citations
5.
El-Lababidi, Rania M., et al.. (2023). Design and Implementation of an Antimicrobial Stewardship Certificate Program in the United Arab Emirates. 2(1). 41–48. 1 indexed citations
6.
El-Lababidi, Rania M., et al.. (2023). 1197. Pharmacist-assisted urine culture review and antimicrobial stewardship interventions in the emergency department: A study from the Middle East Gulf region. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations
7.
El-Lababidi, Rania M., et al.. (2022). Varicella-Zoster Virus (VZV) Meningitis in an Immunocompetent Adult after BNT162b2 mRNA COVID-19 Vaccination: A Case Report. International Journal of Infectious Diseases. 119. 184–186. 6 indexed citations
8.
El-Lababidi, Rania M. & Fatima Osman. (2022). Outcomes of a Pharmacy Internship Program at a Quaternary Care Hospital.. PubMed. 46(4). 251–255. 1 indexed citations
9.
Nekidy, Wasim S. El, et al.. (2022). Tocilizumab and COVID-19: Timing of Administration and Efficacy. Frontiers in Pharmacology. 13. 825749–825749. 34 indexed citations
10.
Almallah, Y. Zaki, Rania M. El-Lababidi, Farah E. Shamout, & D. John Doyle. (2021). Artificial Intelligence: The New Alexander Fleming. Healthcare Informatics Research. 27(2). 168–171. 4 indexed citations
11.
Mallah, Saad I., Omar Ghorab, Tharmegan Tharmaratnam, et al.. (2021). COVID-19: breaking down a global health crisis. Annals of Clinical Microbiology and Antimicrobials. 20(1). 35–35. 206 indexed citations breakdown →
12.
Zoumot, Zaid, Ali S. Wahla, Mateen Uzbeck, et al.. (2021). Pulmonary cavitation: an under-recognized late complication of severe COVID-19 lung disease. BMC Pulmonary Medicine. 21(1). 24–24. 38 indexed citations
13.
Nusair, Ahmad, et al.. (2020). Comprehensive Approach to Reduce Surgical Site Infections in Patients Undergoing Neurosurgical Procedures. Surgical Infections. 22(2). 217–221. 3 indexed citations
14.
El-Lababidi, Rania M. & John G. Rizk. (2020). Cefiderocol: A Siderophore Cephalosporin. Annals of Pharmacotherapy. 54(12). 1215–1231. 66 indexed citations
15.
El-Lababidi, Rania M., et al.. (2020). Treatment of severe pneumonia due to COVID-19 with peginterferon alfa 2a. IDCases. 21. e00837–e00837. 9 indexed citations
16.
El-Lababidi, Rania M., et al.. (2018). A case of acute disseminated encephalomyelitis following Mycoplasma pneumoniae infection. IDCases. 12. 41–43. 5 indexed citations
17.
18.
Chahine, Elias B., et al.. (2014). Engaging Pharmacy Students, Residents, and Fellows in Antimicrobial Stewardship. Journal of Pharmacy Practice. 28(6). 585–591. 19 indexed citations
19.
Karaoui, Lamis R., Rania M. El-Lababidi, & Elias B. Chahine. (2012). Oritavancin: An investigational lipoglycopeptide antibiotic. American Journal of Health-System Pharmacy. 70(1). 23–33. 21 indexed citations
20.
El-Lababidi, Rania M.. (2007). Daptomycin and Linezolid in the Treatment of Vancomycin-Resistant Enterococcal Bacteremia: A Retrospective Analysis of Treatment Outcomes.. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simone Mornese Pinna Breakdown of academic impact, for papers by Yin Mo Breakdown of academic impact, for papers by Mariano Bernardo Breakdown of academic impact, for papers by Tommaso Lupia Breakdown of academic impact, for papers by Navaneeth Narayanan Breakdown of academic impact, for papers by Hamad Abdel Hadi Breakdown of academic impact, for papers by Francesco Vladimiro Segala Breakdown of academic impact, for papers by Mónica Gordón Breakdown of academic impact, for papers by Erin K McCreary Breakdown of academic impact, for papers by Ícaro Boszczowski
Rankless by CCL
2026